81-280 PART 4 OCTOBER 31, NOVEMBER 9, 15, 16, AND 28, 1967 Printed for the use of the Select Committee on Small Business U.S. GOVERNMENT PRINTING OFFICE For sale by the Superintendent of Documents, U.S. Government Printing Office CONTENTS Statement of— Andersen, Mary Louise, second vice president, American Pharmaceu- Apple, Dr. William S., executive director, American Pharmaceutical Caceres, Dr. Cesar A., Chief, Medical Systems Development Labora- tory, heart disease control program, National Center for Chronic Disease Control, Public Health Service, U.S. Department of Health, Education, and Welfare, Washington, D.C.. Callahan, George E., sales projects manager, American Telephone & Eggleston, Max W., president-elect, American Pharmaceutical Asso- Goddard, Dr. James L., Commissioner, Food and Drug Administra- Goodrich, William W., General Counsel, Food and Drug Administra- Laughlin, Dr. John H., attending physicist, Memorial Hospital for Cancer & Allied Diseases, 425 E. 68th Street, New York, N.Y....... Meyer, Dr. Thomas C., associate dean, University of Wisconsin Medical Center, 1415 Linden Drive, Madison, Wis- Nobel, Dr. Joel J., director, Graduate Pain Research Foundation, Pribor, Hugo C., M.D., Ph. D., director, Institute of Laboratory Medicine, Perth Amboy General Hospital, 530 New Brunswick Pumpian, Paul A., Director, Office of Legislative and Governmental Services, Food and Drug Administration, U.S. Department of Health, Education, and Welfare, Washington, D.C.; accompanied Dr. James L. Goddard, Commissioner, FDA Quinnell, Dr. Robert, director, medical relations, Pharmaceutical Manufacturers Association, Washington, D.C.; accompanied C. Joseph Stetler, president, PMA.. Slesser, Dr. A. E., associate director of quality control, Smith, Klein & French Laboratories; accompanied C. Joseph Stetler, president, Steeves, Robert F., director, legal division, American Pharmaceutical Page 1267 1267 1149 1323 1267 1219 1219 1170 1267 |